Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > 90Guppy, couple questions pls

<< Previous

Bullboard Posts

Next >>

Post by bigbanktheoryon Dec 13, 2020 6:32pm

141 Views

Post# 32096654

90Guppy, couple questions pls

Do you know if any of these vaccines coming out have anything at all to do with peptides. I'm assuming you have checked out the ingredients if possible, correct? Also, is there any possibility that the reason these other big bios can't hit 100% is because VXL has filed for patents to protect the missing link. Or am I just daydreaming. Lol. Your comments are welcome. Glta

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?